Neos Therapeutics, Inc. 4
4 · Neos Therapeutics, Inc. · Filed Sep 3, 2015
Insider Transaction Report
Form 4
Engelking Dorothy
VP, Regulatory Affairs
Transactions
- Award
Stock Option (Right to Buy)
2015-09-01+13,000→ 13,000 totalExercise: $25.50Exp: 2025-09-01→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]This stock option vests in equal yearly installments over a four-year period which began on September 1, 2015.